首页> 美国卫生研究院文献>International Journal of Dentistry >Effects of Orally Administered Lactoferrin and Lactoperoxidase-Containing Tablets on Clinical and Bacteriological Profiles in Chronic Periodontitis Patients
【2h】

Effects of Orally Administered Lactoferrin and Lactoperoxidase-Containing Tablets on Clinical and Bacteriological Profiles in Chronic Periodontitis Patients

机译:口服乳铁蛋白和含乳过氧化物酶的片剂对慢性牙周炎患者临床和细菌学特征的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study was undertaken to evaluate the effect of oral administration of lactoferrin (LF) and lactoperoxidase-(LPO-)containing tablet on periodontal condition. Seventy-two individuals with chronic periodontitis were randomly assigned to take either bovine LF and LPO-containing tablets (test group, n = 37) or control tablets (control group, n = 35) every day for 12 weeks. Periodontal parameters and levels of subgingival plaque bacteria, human and bovine LF, and endotoxin in gingival crevicular fluid (GCF) were evaluated at baseline, 1 week, 4 weeks, and 12 weeks. Significant differences were observed in GCF levels of bovine LF between the test and control groups throughout the study (P < .05). However, clinical and bacteriological parameter values proved comparable between the two groups at 1 week to 12 weeks. Therefore, the effect of oral administration of LF and LPO-containing tablets might be weak on periodontal and bacteriological profile in this study.
机译:进行这项研究以评估口服乳铁蛋白(LF)和含乳过氧化物酶-(LPO-)的片剂对牙周病的影响。随机分配72名患有慢性牙周炎的人,每天服用含牛LF和LPO的药片(测试组,n = 37)或对照组药片(对照组,n = 35),持续12周。在基线,1周,4周和12周时评估牙周参数和龈沟液(GCF)中的龈下菌斑细菌,人和牛LF以及内毒素的水平。在整个研究过程中,测试组和对照组之间的牛LF GCF水平存在显着差异(P <.05)。然而,在1周至12周时,两组的临床和细菌学参数值证明具有可比性。因此,本研究中口服含LF和LPO的片剂对牙周和细菌学特征的作用可能较弱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号